Abstract

In previous research, voltage-dependent anion channel protein 2 (VDAC2) and the receptor of activated protein C kinase 1 (RACK1) in flounder (Paralichthys olivaceus) were confirmed as functional receptors for lymphocystis disease virus (LCDV) entry; however, the underlying mechanism of VDAC2- and RACK1-mediated LCDV entry remains unclear. In this study, we elucidated the endocytosis pathway of LCDV entry into flounder gill (FG) cells by treatment with specific inhibitory agents, siRNAs, and co-localization analysis. LCDV entry was significantly inhibited by the disruption of caveolae-mediated endocytosis, dynamin, and microtubules, and the knockdown of caveoline-1 and dynamin expression, but was not inhibited by the disruption of clathrin-mediated endocytosis, micropinocytosis, or low-pH conditions. The disruption of caveolae-mediated and clathrin-mediated endocytosis was verified by the internalization of cholera toxin subunit B (CTB) and transferrin, respectively. Confocal immunofluorescence assay demonstrated that LCDV was co-localized with VDAC2 and RACK1, CTB was co-localized with VDAC2 and RACK1 and partially with LCDV, but transferrin was not co-localized with LCDV, VDAC2, or RACK1, indicating that LCDV utilized the same pathway as CTB, i.e., caveolae-mediated endocytosis. This was different from the pathway of transferrin, which used clathrin-mediated endocytosis. Furthermore, caveolin-1 was co-localized with LCDV, VDAC2, and RACK1, suggesting that caveolin-1 was involved in LCDV entry. These results revealed for the first time that LCDV entered into FG cells via caveolae-mediated endocytosis facilitated by VDAC2 and RACK1 receptors, relying on dynamin and microtubules in a pH-independent manner, which provided new insight into the molecular mechanisms of LCDV entry and potential for the development of antiviral agents, expanding our understanding of iridovirus infection.

Highlights

  • Lymphocystis disease virus (LCDV), an enveloped DNA virus belonging to the genus Lymphocystivirus within the family Iridoviridae [1,2], is the causative agent of lymphocystis disease, which infects more than 140 wild and cultured species of marine, brackish, and freshwater fish worldwide [3,4]

  • Frog virus 3 (FV3), which is a type species of the genus Ranavirus and recognized as a model for iridoviruses, enters into mammalian cells (BHK-21) via the clathrin-mediated endocytosis [48], while tiger frog virus (TFV) enters into HepG2 cells via the caveola-mediated endocytosis pathway in a pH-dependent manner [49], and Singapore grouper iridovirus (SGIV) enters into the grouper spleen (GS) cells by clathrin-mediated endocytosis and micropinocytosis [45]

  • The LCDV 32 kDa viral attachment protein (VAP) is encoded by the ORF038 gene of LCDV isolated in China (LCDV-C) [14,50], and the LCDV-C ORF038 gene had homologues with genes encoding SGIV VP19 and rana grylio virus envelope protein 2L [50,51]

Read more

Summary

Introduction

Lymphocystis disease virus (LCDV), an enveloped DNA virus belonging to the genus Lymphocystivirus within the family Iridoviridae [1,2], is the causative agent of lymphocystis disease, which infects more than 140 wild and cultured species of marine, brackish, and freshwater fish worldwide [3,4]. We have identified 27.8 kDa protein as a cellular receptor for LCDV from flounder (Paralichthys olivaceus) gill (FG) cells [11], a cell line derived from the gill tissue of a flounder [12]. A 32 kDa envelope protein of LCDV was found to function as a viral attachment protein (VAP), and the interaction of the 32 kDa VAP with the 27.8 kDa putative receptor protein initiates LCDV infection in FG cells [13]; monoclonal antibodies (MAbs) against the 32 kDa VAP can effectively neutralize LCDV infection [14]. Voltage-dependent anion channel protein 2 (VDAC2) and the receptor of activated protein C kinase 1 (RACK1) have been identified among the putative 27.8 kDa receptor protein as the functional receptor for LCDV entry [15].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.